ASQ 509 April 2023 General Meeting

Thursday, Apr 20, 2023 at 7:00 PM to 8:30 PM EDT

Register Now

Registration

Sale ended

Virtual Ticket Partial Approval - Free

ASQ Section 509 is inviting you to a scheduled Zoom meeting. Topic: April 2023 Workshop and General Meeting Time: Apr 20, 2023, 06:30 PM Eastern Time (US and Canada) Join Zoom Meeting https://us02web.zoom.us/j/85696662579 Meeting ID: 856 9666 2579 One tap mobile +13017158592,,85696662579# US (Washington DC) +13092053325,,85696662579# US Dial by your location +1 301 715 8592 US (Washington DC) +1 309 205 3325 US +1 312 626 6799 US (Chicago) +1 646 931 3860 US +1 929 205 6099 US (New York) +1 305 224 1968 US +1 253 205 0468 US +1 253 215 8782 US (Tacoma) +1 346 248 7799 US (Houston) +1 360 209 5623 US +1 386 347 5053 US +1 507 473 4847 US +1 564 217 2000 US +1 669 444 9171 US +1 669 900 6833 US (San Jose) +1 689 278 1000 US +1 719 359 4580 US Meeting ID: 856 9666 2579 Find your local number: https://us02web.zoom.us/u

Enter your discount code

  • Fee
  • Total amount

1. Select Seats

2. Review and Proceed

Thursday, Apr 20, 2023 at 7:00 PM to 8:30 PM EDT

‘Building a Quality Startuppresented by Dr. Milton Greenberg

Description:

Startup companies are a vehicle to perform the research and development required to bring new products or services to market. Technology startups span the fields of computer science, engineering, biosciences, and finance, with a focus on innovation, scalability, and growth. Dr. Greenberg will detail the role of technology startups in the innovation ecosystem, including the perils and rewards encountered when building a quality startup.

Speaker Bio

Milton L. Greenberg, Ph.D. is an Assistant Adjunct Professor in the Department of Physiology and Biophysics at the University of California, Irvine, School of Medicine. Dr. Greenberg serves as the lead lecturer and course coordinator for Medical Physiology and Medical Immunology for first-year medical students. Dr. Greenberg is the co-founder and CEO of Vivreon Biosciences, a preclinical stage pharmaceutical company developing first-in-class therapeutics for chronic inflammatory diseases. He is Principal Investigator on research grant awards funded by the National Institute on Aging, National Cancer Institute, National Institute of Allergy and Infectious Disease, Alzheimer’s Drug Discovery Foundation, Michael J. Fox Foundation, and Johnson and Johnson Innovation.

Dr. Greenberg received his bachelor’s degree in biochemistry at the University of Maryland, Baltimore County, where he trained under Dr. Sergei Atamas at the University of Maryland Medical Center. Dr. Greenberg received his Ph.D. in Biomedical Sciences from the University of California, Irvine School of Medicine with a focus in immunology and biophysics in the laboratory of Dr. Michael Cahalan.

Contact information will be provided upon request.